Insys Therapeutics Price Target & Analyst Ratings (NASDAQ:INSY) Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Insys Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Today's Range N/A50-Day Range$0.23MA: $23,687,640.18▼$65,799,000.0052-Week Range N/AVolumeN/AAverage Volume9.52 million shsMarket Capitalization$21.71 millionP/E RatioN/ADividend YieldN/ABeta3.21 ProfileAnalyst RatingsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Analyst Ratings Insys Therapeutics (NASDAQ:INSY) Price Target and Consensus Rating (How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.4 Wall Street analysts have issued ratings and price targets for Insys Therapeutics in the last 12 months. Their average twelve-month price target is $6.60The high price target for INSY is $11.00 and the low price target for INSY is $4.00. There are currently 1 sell rating, 1 hold rating and 2 buy ratings for the stock, resulting in a consensus rating of "Hold."Today30 Days Ago90 Days Ago180 Days AgoConsensus Rating: HoldHoldHoldBuyConsensus Rating Score: 22.214.171.1242.50Ratings Breakdown: 1 Sell Rating(s)1 Hold Rating(s)2 Buy Rating(s)0 Strong Buy Rating(s)1 Sell Rating(s)1 Hold Rating(s)2 Buy Rating(s)0 Strong Buy Rating(s)1 Sell Rating(s)1 Hold Rating(s)3 Buy Rating(s)0 Strong Buy Rating(s)1 Sell Rating(s)1 Hold Rating(s)4 Buy Rating(s)0 Strong Buy Rating(s)Consensus Price Target: $6.60$6.60$7.28$7.28Price Target Upside: N/A594.66% upside666.24% upside29.31% upsideInsys Therapeutics (NASDAQ:INSY) Consensus Price Target History Insys Therapeutics (NASDAQ:INSY) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails5/14/2019Janney Montgomery ScottDowngradeBuy ➝ NeutralHigh3/8/2019Piper Jaffray CompaniesSet Price TargetSell$4.00Medium3/8/2019Royal Bank of CanadaLower Price TargetOutperform ➝ Outperform$9.00 ➝ $7.00High1/22/2019Cantor FitzgeraldInitiated CoverageOverweight$4.40High8/10/2018Jefferies Financial GroupReiterated RatingBuy$10.00Low5/9/2018OppenheimerReiterated RatingHoldLow(Data available from 10/19/2017 forward) This page was last updated on 10/19/2019 by MarketBeat.com StaffFeatured Article: Inverted Yield Curve Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.